Articles dans des revues avec comité de lecture (55)
  1. 22. Sá, J., Fernandes, D. L. A., Szlachetko, J., Czapla-Masztafiak, J., Lipiec, E., Kayser, Y., Kwiatek, W., Wood, B., Deacon, G. G., Berger, G., & Dufrasne, F. (2015). The use of Resonant X-ray Emission Spectroscopy (RXES) for the electronic analysis of metal complexes and their interactions with biomolecules. Drug Discovery Today: Technologies, 16, 1-6. doi:10.1016/j.ddtec.2015.07.001
  2. 23. Dufrasne, F. (2015). Technologies to develop new metal medicines. Drug Discovery Today: Technologies, 16, 31-32. doi:10.1016/j.ddtec.2015.10.001
  3. 24. Soubhye, J., Chikh Alard, I., Van Antwerpen, P., & Dufrasne, F. (2015). Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis. Future Medicinal Chemistry, 7(11), 1431-1456. doi:10.4155/fmc.15.74
  4. 25. Berger, G., Fusaro, L., Luhmer, M., Czapla-Masztafiak, J., Lipiec, E., Szlachetko, J., Kayser, Y., Fernandes, D. L. A., Sá, J., Dufrasne, F., & Bombard, S. (2015). Insights into the structure-activity relationships of chiral 1,2-diaminophenylalkane platinum(II) anticancer derivatives. JBIC. Journal of biological inorganic chemistry. doi:10.1007/s00775-015-1270-6
  5. 26. Berger, G., Gelbcke, M., Neve, J., Dufrasne, F., Cauet, E., & Luhmer, M. (2015). Erratum:Corrigendum to "synthesis of 15N-labeled vicinal diamines through N-activated chiral aziridines: Tools for the NMR study of platinum-based anticancer compounds" (Tetrahedron Letters (2013) 54 (545-548) doi:10.1016/j.tetlet.2014.11.086)). Tetrahedron letters, 56(2), 485. doi:10.1016/j.tetlet.2014.11.086
  6. 27. Berger, G., Leclercqz, H., Derenne, A., Gelbcke, M., Goormaghtigh, E., Neve, J., Mathieu, V., & Dufrasne, F. (2014). Synthesis and in vitro characterization of platinum(II) anticancer coordinates using FTIR spectroscopy and NCI COMPARE: A fast method for new compound discovery. Bioorganic & medicinal chemistry, 22(13), 3527-3536. doi:10.1016/j.bmc.2014.04.017
  7. 28. Soubhye, J., Aldib, I., Prévost, M., Elfving, B., Gelbcke, M., Podrecca, M., Conotte, R., Colet, J.-M., Furtmüller, P. G., Delporte, C., Rousseau, A., Vanhaeverbeek, M., Neve, J., Obinger, C., Zouaoui Boudjeltia, K., Van Antwerpen, P., & Dufrasne, F. (2014). Hybrid molecules inhibiting myeloperoxidase activity and serotonin reuptake: a possible new approach of major depressive disorders with inflammatory syndrome. Journal of Pharmacy and Pharmacology, 66(8), 1122-1132. doi:10.1111/jphp.12236
  8. 29. Tourrel, F., Laudenbach, V., Gonzalez, B. J., Jégou, S., De Lendeu, P. K., Abily-Donval, L., Chollat, C., Marret, S., Dufrasne, F., Compagnon, P., Ramdani, Y., & Dureuil, B. (2014). The antiapoptotic effect of remifentanil on the immature mouse brain: An ex vivo study. Anesthesia and analgesia, 118(5), 1041-1051. doi:10.1213/ANE.0000000000000159
  9. 30. Moreno Y Banuls, L., Urban, E., Gelbcke, M., Dufrasne, F., Kopp, B., Kiss, R., & Zehl, M. (2013). Structure-Activity Relationship Analysis of Bufadienolide-Induced in Vitro Growth Inhibitory Effects on Mouse and Human Cancer Cells. Journal of natural products, 76(6), 1078-1084. doi:10.1021/np400034d
  10. 31. Soubhye, J., Aldib, I., Elfving, B., Gelbcke, M., Furtmüller, P. G., Podrecca, M., Conotte, R., Colet, J.-M., Rousseau, A., Reye, F., Sarakbi, A., Vanhaeverbeek, M., Kauffmann, J.-M., Obinger, C., Neve, J., Prévost, M., Zouaoui Boudjeltia, K., Dufrasne, F., & Van Antwerpen, P. (2013). Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors. Journal of medicinal chemistry, 56(10), 3943-3958. doi:10.1021/jm4001538
  11. 32. Berger, G., Gelbcke, M., Cauet, E., Luhmer, M., Neve, J., & Dufrasne, F. (2013). Synthesis of 15N-labeled vicinal diamines through N-activated chiral aziridines: tools for the NMR study of platinum-based anticancer compounds. Tetrahedron letters, 54(6), 545-548. doi:10.1016/j.tetlet.2012.11.079
  12. 33. Aldib, I., Soubhye, J., Zouaoui Boudjeltia, K., Vanhaeverbeek, M., Rousseau, A., Furtmüller, P. G., Obinger, C., Dufrasne, F., Neve, J., Van Antwerpen, P., & Prévost, M. (2012). Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening. Journal of medicinal chemistry, 55(16), 7208-7218. doi:10.1021/jm3007245
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>